The effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine

The Pharmacogenomics Journal
T SugaiT Someya

Abstract

We investigated the effect of 5-hydroxytryptamine 3A and 3B receptor (HTR3A and HTR3B) gene polymorphisms on nausea induced by paroxetine in Japanese psychiatric patients. Blood samples were collected from 78 individuals after at least 2 weeks treatment with the same daily dose of paroxetine. The patients visited every 2 weeks and the paroxetine dose was changed in response to their clinical symptoms. Nausea was assessed at each visit. The Tyr129Ser polymorphism of the HTR3B gene had a significant effect on the incidence of nausea (P=0.038). Logistic regression analysis also showed that patients with the Tyr/Tyr genotype had a 3.95-fold (P=0.048) higher risk of developing nausea than patients with the Ser allele. HTR3A gene polymorphisms and the CYP2D6 gene polymorphisms had no significant effect on the incidence of nausea. The mean score of nausea severity was corrected by the Bonferroni test. HTR3B gene polymorphisms are significant predictors of paroxetine-induced nausea.

References

Jan 1, 1992·Drugs·S KasperH J Möller
Jan 1, 1992·Oncology·M B Tyers, A J Freeman
Mar 1, 1992·Clinical Pharmacology and Therapeutics·S H SindrupT C Tasker
Feb 1, 1990·Canadian Journal of Physiology and Pharmacology·D J Stewart
Jan 1, 1989·Acta Psychiatrica Scandinavica. Supplementum·C M KayeW H Greb
Jul 1, 1994·The American Journal of Psychiatry·R Bergeron, P Blier
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Dec 1, 2001·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·A OgataT Iga
Oct 5, 2002·Schizophrenia Research·Blanca GutiérrezRobert W Kerwin
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Pierre-Benoit TremblayJurgen Brockmoller
Sep 30, 2003·The American Journal of Psychiatry·Greer M MurphyAlan F Schatzberg
Sep 7, 2004·European Journal of Clinical Pharmacology·Kazushi SawamuraToshiyuki Someya
Sep 25, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Bernd FrankGudrun Rappold

❮ Previous
Next ❯

Citations

Jan 11, 2008·Proceedings of the National Academy of Sciences of the United States of America·Karen KrzywkowskiAnders A Jensen
Jul 14, 2007·International Journal of Clinical Practice·Martin C Michel
Apr 11, 2007·BMC Medical Genetics·Gustavo J J SilvaJosé E Krieger
Dec 22, 2010·Journal of Psychiatry & Neuroscience : JPN·Stefano PorcelliAlessandro Serretti
Dec 21, 2010·Journal of Psychiatry & Neuroscience : JPN·Simon N Young
May 17, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Eivor A LaugsandPål Klepstad
Feb 24, 2011·Current Opinion in Pharmacology·Paul A Davies
Sep 14, 2010·Clinics in Laboratory Medicine·Peter P Zandi, Jennifer T Judy
Jul 14, 2010·Pharmacology & Therapeutics·Jutta WalstabBeate Niesler
Feb 18, 2010·The Psychiatric Clinics of North America·Peter P Zandi, Jennifer T Judy
Jul 16, 2013·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Chiara FabbriAlessandro Serretti
Jan 12, 2013·Journal of Neurochemistry·Yukiko NakamuraShoichi Shimada
Oct 29, 2013·Pharmacology, Biochemistry, and Behavior·Olivia F O'LearyJohn F Cryan
Sep 2, 2008·Neuropharmacology·Nicholas M BarnesJohn A Peters
Aug 16, 2016·The Psychiatric Clinics of North America·Joseph F Goldberg, Carrie L Ernst
Aug 17, 2016·International Journal of Molecular Sciences·Aizati N A DaudBob Wilffert
Oct 21, 2016·Human Mutation·Jacopo CelliBeate Niesler
Aug 19, 2007·The International Journal of Neuropsychopharmacology·Misuzu TanakaKazunori Mine
Feb 28, 2008·Pharmacogenetics and Genomics·Cornelia MeinekeJürgen Brockmöller
Sep 11, 2009·Pharmacogenetics and Genomics·Christian HammerBeate Niesler
May 10, 2008·Pharmacogenomics·Beate NieslerGudrun Rappold
Jul 4, 2008·Pharmacogenomics·Eugene Lin, Po See Chen
Jun 30, 2009·Pharmacotherapy·Kelan L H Thomas, Vicki L Ellingrod
Oct 22, 2009·Pharmacogenomics·Ibrahim A Abdel-Hamid, Karl-Erik Andersson
Jul 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Stefano PorcelliDiana De Ronchi
Mar 3, 2012·Pharmacogenomics·Sneha Narasimhan, Falk W Lohoff
Oct 25, 2013·International Review of Psychiatry·C Anthony AltarDavid Mrazek
Jun 3, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Chiara FabbriAlessandro Serretti
Jun 2, 2015·Expert Opinion on Drug Metabolism & Toxicology·Kristina Probst-SchendzielorzJulia C Stingl
Oct 21, 2006·Biochemical Society Transactions·K Krzywkowski

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.